Cargando…
Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles
Furosemide (FSM) is commonly used in the treatment of edema associated with congestive cardiac failure, cirrhosis of the liver, renal disease, including the nephrotic syndrome and hypertension. However, in ascites, it is clinically limited due to its frequent dosing and short biological half-life an...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791168/ https://www.ncbi.nlm.nih.gov/pubmed/31620185 http://dx.doi.org/10.4103/1735-5362.253356 |